期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Sclerosing cholangitis secondary to bleomycin-iodinated embolization for liver hemangioma 被引量:6
1
作者 Shuo Jin Xiao-Ju Shi +2 位作者 Xiao-Dong Sun Si-Yuan Wang Guang-Yi Wang 《World Journal of Gastroenterology》 SCIE CAS 2014年第46期17680-17685,共6页
Sclerosing cholangitis(SC)is a rarely reported morbidity secondary to transcatheter arterial chemoembolization(TACE)with bleomycin-iodinated oil(BIO)for liver cavernous hemangioma(LCH).This report retrospectively eval... Sclerosing cholangitis(SC)is a rarely reported morbidity secondary to transcatheter arterial chemoembolization(TACE)with bleomycin-iodinated oil(BIO)for liver cavernous hemangioma(LCH).This report retrospectively evaluated the diagnostic and therapeutic course of a patient with LDH who presented obstructive jaundice 6 years after TACE with BIO.Preoperative imaging identified a suspected malignant biliary stricture located at the convergence of the left and right hepatic ducts.Operative exploration demonstrated a full-thickness sclerosis of the hilar bile duct with right hepatic duct stricture and right lobe atrophy.Radical hepatic hilar resection with right-side hemihepatectomy and Roux-en-Y hepaticojejunostomy was performed because hilar cancer could not be excluded on frozen biopsy.Pathological results showed chronic pyogenic inflammation of the common and right hepatic ducts with SC in the portal area.Secondary SC is a long-term complication that may occur in LCH patients after TACE with BIO and must be differentiated from hilar malignancy.Hepatic duct plasty is a definitive but technically challenging treatment modality for secondary SC. 展开更多
关键词 Sclerosing cholangitis Secondary Transcatheter arterial chemoembolization Bleomycin-iodinated oil liver cavernous hemangioma Hilar stricture Differential diagnosis Definitive surgery
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部